Skip to main content
. 2023 Oct 20;102(42):e35568. doi: 10.1097/MD.0000000000035568

Table 2.

Baseline and after-treatment outcome measures.

Robot group (n = 26) Control group (n = 23)
Pre Post P value* Pre Post P value*
FAC 0.96 ± 0.87 3.35 ± 1.23 <.001 1.04 ± 0.93 2.48 ± 1.12 <.001
MI 53.19 ± 15.57 67.54 ± 14.28 <.01 43.48 ± 18.11 56.09 ± 13.47 <.01
FMA-LE 19.85 ± 8.92 27.42 ± 4.87 <.01 16.13 ± 8.83 21.65 ± 7.86 <.01
RMI 4.35 ± 2.64 9.15 ± 2.95 <.01 3.91 ± 2.17 8.30 ± 2.74 <.01
10MWT (m/s) 0.30 ± 0.26 0.60 ± 0.36 <.01 0.22 ± 0.13 0.43 ± 0.29 <.01
BBS 25.08 ± 22.67 47.58 ± 21.33 <.01 19.65 ± 21.25 38.87 ± 22.56 <.01
MBI 34.50 ± 16.82 63.85 ± 19.52 <.01 34.48 ± 16.60 60.87 ± 21.45 <.01

10MWT = 10 meter walk test, BBS = Berg balance scale, FAC = functional ambulatory category, FMA-LE = Fugl Meyer assessment-lower extremity, MBI = modified Barthel index, MI = motricity index-lower extremity, RMI = rivermead mobility index.

*

Wilcoxon signed rank test.